When we examined the differences in the relevant analytes between HIV infected and HIV uninfected individuals at active TB and post-successful TB treatment, we observed that LBP was significantly elevated in HIV infected individuals irrespective of the TB status, indicating that the HIV infection and resulting increase in systemic LPS exposure are the predominant drivers of increased LBP levels in co-infected patients. The gene discussed is LBP; the disease is HIV infectious disease.